Proactiveinvestors USA & Canada Mylan Inc. https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Mylan Inc. RSS feed en Fri, 07 Aug 2020 07:44:13 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Mylan and Teva decline as report says generic-drug companies face probe of alleged price fixing https://www.proactiveinvestors.com/companies/news/210904/mylan-and-teva-decline-as-report-says-generic-drug-companies-face-probe-of-alleged-price-fixing-210904.html Mon, 10 Dec 2018 19:42:00 -0500 https://www.proactiveinvestors.com/companies/news/210904/mylan-and-teva-decline-as-report-says-generic-drug-companies-face-probe-of-alleged-price-fixing-210904.html Mylan to market biosimilar version of Humira across Europe https://www.proactiveinvestors.com/companies/news/194787/mylan-to-market-biosimilar-version-of-humira-across-europe-194787.html Wed, 11 Apr 2018 19:03:00 -0400 https://www.proactiveinvestors.com/companies/news/194787/mylan-to-market-biosimilar-version-of-humira-across-europe-194787.html Mylan to launch two new low-cost HIV combination treatments in the US https://www.proactiveinvestors.com/companies/news/192541/mylan-to-launch-two-new-low-cost-hiv-combination-treatments-in-the-us-192541.html Fri, 02 Mar 2018 15:13:00 -0500 https://www.proactiveinvestors.com/companies/news/192541/mylan-to-launch-two-new-low-cost-hiv-combination-treatments-in-the-us-192541.html Mylan's fourth quarter earnings beat expectations but revenue undershoots forecasts https://www.proactiveinvestors.com/companies/news/192451/mylan-s-fourth-quarter-earnings-beat-expectations-but-revenue-undershoots-forecasts-192451.html Thu, 01 Mar 2018 14:12:00 -0500 https://www.proactiveinvestors.com/companies/news/192451/mylan-s-fourth-quarter-earnings-beat-expectations-but-revenue-undershoots-forecasts-192451.html Mylan NV, Cardinal Health, Priceline Group Inc and Smith & Wesson - PRE-MARKET https://www.proactiveinvestors.com/companies/news/186804/mylan-nv-cardinal-health-priceline-group-inc-and-smith-wesson-pre-market-186804.html Mon, 06 Nov 2017 12:41:00 -0500 https://www.proactiveinvestors.com/companies/news/186804/mylan-nv-cardinal-health-priceline-group-inc-and-smith-wesson-pre-market-186804.html Mylan NV shares rocket thanks to FDA approval https://www.proactiveinvestors.com/companies/news/185058/mylan-nv-shares-rocket-thanks-to-fda-approval-185058.html Wed, 04 Oct 2017 18:03:00 -0400 https://www.proactiveinvestors.com/companies/news/185058/mylan-nv-shares-rocket-thanks-to-fda-approval-185058.html Mylan pushes back all 2017 US drugs launches to next year https://www.proactiveinvestors.com/companies/news/182208/mylan-pushes-back-all-2017-us-drugs-launches-to-next-year-182208.html Wed, 09 Aug 2017 13:53:00 -0400 https://www.proactiveinvestors.com/companies/news/182208/mylan-pushes-back-all-2017-us-drugs-launches-to-next-year-182208.html Mylan, Vantiv,Achillion Pharmaceuticals and more - PRE-MARKET https://www.proactiveinvestors.com/companies/news/182199/mylan-vantivachillion-pharmaceuticals-and-more-pre-market-182199.html Wed, 09 Aug 2017 12:34:00 -0400 https://www.proactiveinvestors.com/companies/news/182199/mylan-vantivachillion-pharmaceuticals-and-more-pre-market-182199.html Mylan heads lower as it receives “tentative approval” for HIV/AIDS drug https://www.proactiveinvestors.com/companies/news/182070/mylan-heads-lower-as-it-receives-tentative-approval-for-hivaids-drug-182070.html Mon, 07 Aug 2017 13:23:00 -0400 https://www.proactiveinvestors.com/companies/news/182070/mylan-heads-lower-as-it-receives-tentative-approval-for-hivaids-drug-182070.html Mylan surges after drawing line under EpiPen scandal https://www.proactiveinvestors.com/companies/news/167160/mylan-surges-after-drawing-line-under-epipen-scandal-167160.html Mon, 10 Oct 2016 13:22:00 -0400 https://www.proactiveinvestors.com/companies/news/167160/mylan-surges-after-drawing-line-under-epipen-scandal-167160.html New York prosecutors launch Mylan Pharma EpiPen anti-trust probe https://www.proactiveinvestors.com/companies/news/160596/new-york-prosecutors-launch-mylan-pharma-epipen-anti-trust-probe-160596.html Tue, 06 Sep 2016 21:10:00 -0400 https://www.proactiveinvestors.com/companies/news/160596/new-york-prosecutors-launch-mylan-pharma-epipen-anti-trust-probe-160596.html Mylan boss take the fight to Hillary https://www.proactiveinvestors.com/companies/news/129721/mylan-boss-take-the-fight-to-hillary-129721.html Thu, 25 Aug 2016 13:33:00 -0400 https://www.proactiveinvestors.com/companies/news/129721/mylan-boss-take-the-fight-to-hillary-129721.html Mylan's Perrigo bid continues after US court ruling https://www.proactiveinvestors.com/companies/news/116880/mylan-s-perrigo-bid-continues-after-us-court-ruling-116880.html Fri, 30 Oct 2015 11:36:00 -0400 https://www.proactiveinvestors.com/companies/news/116880/mylan-s-perrigo-bid-continues-after-us-court-ruling-116880.html Perrigo urges shareholders to turn down Mylan’s hostile bid https://www.proactiveinvestors.com/companies/news/115173/perrigo-urges-shareholders-to-turn-down-mylans-hostile-bid-115173.html Thu, 17 Sep 2015 20:26:00 -0400 https://www.proactiveinvestors.com/companies/news/115173/perrigo-urges-shareholders-to-turn-down-mylans-hostile-bid-115173.html Mylan offers Perrigo shareholders US$27bn takeover https://www.proactiveinvestors.com/companies/news/115172/mylan-offers-perrigo-shareholders-us27bn-takeover-115172.html Mon, 14 Sep 2015 16:50:00 -0400 https://www.proactiveinvestors.com/companies/news/115172/mylan-offers-perrigo-shareholders-us27bn-takeover-115172.html Mylan's bid for Perrigo to be formally launched on Monday https://www.proactiveinvestors.com/companies/news/115171/mylan-s-bid-for-perrigo-to-be-formally-launched-on-monday-115171.html Tue, 08 Sep 2015 19:14:00 -0400 https://www.proactiveinvestors.com/companies/news/115171/mylan-s-bid-for-perrigo-to-be-formally-launched-on-monday-115171.html Mylan launches generic version of Lidoderm Patch; shares gain in premarket trade https://www.proactiveinvestors.com/companies/news/115170/mylan-launches-generic-version-of-lidoderm-patch-shares-gain-in-premarket-trade-115170.html Mon, 10 Aug 2015 15:29:00 -0400 https://www.proactiveinvestors.com/companies/news/115170/mylan-launches-generic-version-of-lidoderm-patch-shares-gain-in-premarket-trade-115170.html Mylan to buy Abbott's non-U.S. assets in $5.3 bln deal https://www.proactiveinvestors.com/companies/news/102274/mylan-to-buy-abbotts-non-us-assets-in-53-bln-deal--55399.html Mon, 14 Jul 2014 13:47:00 -0400 https://www.proactiveinvestors.com/companies/news/102274/mylan-to-buy-abbotts-non-us-assets-in-53-bln-deal--55399.html Swedish Meda rebuffs rival Mylan takeover offer https://www.proactiveinvestors.com/companies/news/100687/swedish-meda-rebuffs-rival-mylan-takeover-offer-53233.html Fri, 04 Apr 2014 19:53:00 -0400 https://www.proactiveinvestors.com/companies/news/100687/swedish-meda-rebuffs-rival-mylan-takeover-offer-53233.html Mylan launches generic Lipitor in five European countries https://www.proactiveinvestors.com/companies/news/86127/mylan-launches-generic-lipitor-in-five-european-countries-29017.html Fri, 11 May 2012 15:54:00 -0400 https://www.proactiveinvestors.com/companies/news/86127/mylan-launches-generic-lipitor-in-five-european-countries-29017.html Mylan shares up as it boosts earnings forecast for 2012 https://www.proactiveinvestors.com/companies/news/86088/mylan-shares-up-as-it-boosts-earnings-forecast-for-2012-28956.html Thu, 10 May 2012 18:03:00 -0400 https://www.proactiveinvestors.com/companies/news/86088/mylan-shares-up-as-it-boosts-earnings-forecast-for-2012-28956.html Mylan Q4 earnings soar from prior year https://www.proactiveinvestors.com/companies/news/83853/mylan-q4-earnings-soar-from-prior-year-25227.html Tue, 21 Feb 2012 13:31:00 -0500 https://www.proactiveinvestors.com/companies/news/83853/mylan-q4-earnings-soar-from-prior-year-25227.html Mylan receives tentative US FDA approval for HIV/AIDS cocktail treatment https://www.proactiveinvestors.com/companies/news/79949/mylan-receives-tentative-us-fda-approval-for-hivaids-cocktail-treatment-18606.html Tue, 20 Sep 2011 17:19:00 -0400 https://www.proactiveinvestors.com/companies/news/79949/mylan-receives-tentative-us-fda-approval-for-hivaids-cocktail-treatment-18606.html Mylan sued by Endo over migraine drug rights https://www.proactiveinvestors.com/companies/news/79213/mylan-sued-by-endo-over-migraine-drug-rights-17335.html Wed, 17 Aug 2011 16:11:00 -0400 https://www.proactiveinvestors.com/companies/news/79213/mylan-sued-by-endo-over-migraine-drug-rights-17335.html Mylan expands license to Gilead's HIV/AIDS pipeline to more developing countries https://www.proactiveinvestors.com/companies/news/78568/mylan-expands-license-to-gileads-hivaids-pipeline-to-more-developing-countries-16227.html Tue, 12 Jul 2011 14:19:00 -0400 https://www.proactiveinvestors.com/companies/news/78568/mylan-expands-license-to-gileads-hivaids-pipeline-to-more-developing-countries-16227.html Mylan's fourth quarter net profit falls, but sales rise https://www.proactiveinvestors.com/companies/news/76433/mylans-fourth-quarter-net-profit-falls-but-sales-rise-12569.html Thu, 24 Feb 2011 14:49:00 -0500 https://www.proactiveinvestors.com/companies/news/76433/mylans-fourth-quarter-net-profit-falls-but-sales-rise-12569.html Mylan subsidiary receives license to market generic HIV/AIDS drug in developing countries https://www.proactiveinvestors.com/companies/news/75963/mylan-subsidiary-receives-license-to-market-generic-hivaids-drug-in-developing-countries-11814.html Thu, 27 Jan 2011 18:57:00 -0500 https://www.proactiveinvestors.com/companies/news/75963/mylan-subsidiary-receives-license-to-market-generic-hivaids-drug-in-developing-countries-11814.html Mylan receives FDA approval for leukemia injection medication https://www.proactiveinvestors.com/companies/news/74113/-mylan-receives-fda-approval-for-leukemia-injection-medication-8897.html Mon, 04 Oct 2010 19:44:00 -0400 https://www.proactiveinvestors.com/companies/news/74113/-mylan-receives-fda-approval-for-leukemia-injection-medication-8897.html Mylan Inc gets FDA approval for generic version of Merck's Zocor https://www.proactiveinvestors.com/companies/news/73270/mylan-inc-gets-fda-approval-for-generic-version-of-mercks-zocor-6542.html Fri, 18 Jun 2010 19:37:00 -0400 https://www.proactiveinvestors.com/companies/news/73270/mylan-inc-gets-fda-approval-for-generic-version-of-mercks-zocor-6542.html